Anne F. Schott, MD
Advertisement
Articles by Anne F. Schott, MD
24 ARV-471, a PROTAC Estrogen Receptor (ER) Degrader in Advanced ER+/Human Epidermal Growth Factor Receptor 2 (HER2)– Breast Cancer: Phase 2 Expansion (VERITAC) of a Phase 1/2 Study
BySara A. Hurvitz, MD,Anne F. Schott, MD,Cynthia X. Ma, MD, PhD,Erika P. Hamilton, MD,Rita Nanda, MD,George Zahrah,Natasha Hunter, MD,Antoinette R. Tan,Melinda L. Telli, MD,Jesus Anampa Mesias,Rinath Jeselsohn,Pamela N. Munster, MD,Haolan Lu,Richard Gedrich,Cecile Mather,Janaki Parameswaran,Hyo S Han
This second edition of the text edited by Bland and Copeland represents a comprehensive reference that reviews the history, pathobiology, and current clinical management of diseases of the breast. Much more than a book about breast
Advertisement
Latest Updated Articles
- The Breast: Comprehensive Management of Benign and Malignant Diseases, Second Edition
Published: February 1st 2001 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
mRNA Vaccine/Pembrolizumab Shows Sustained 5-Year RFS in High-Risk Melanoma
2
FDA Grants Breakthrough Therapy Designation to Sofetabart Mipitecan in PROC
3
FDA Accepts NDA for Gedatolisib in HR+/HER2–, PIK3CA Wild-Type Breast Cancer
4
FDA Grants Fast Track Designation to LBL-024 in Extrapulmonary NEC
5